Planegg/Martinsried, May 30, 2023. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will participate at the BIO. | May 30, 2023
Planegg/Martinsried, May 8, 2023. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will present at the following. | May 8, 2023
Martinsried/Munich, April 3, 2023. Medigene AG , an early stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, and the National. | April 3, 2023